Allonge to Promissory Note between Bionik Laboratories Corp. and Star SCI (September 24, 2019)

Summary

Bionik Laboratories Corp. and Star SCI have agreed to amend their existing $500,000 promissory note. The amendment changes the definition of the note's maturity date to be the date when Bionik Laboratories receives a total of $9,000,000 in gross proceeds from selling its securities after the original issue date. All other terms of the original promissory note remain unchanged. This amendment is effective as of September 24, 2019.

EX-10.1 2 tv530340_ex10-1.htm EXHIBIT 10.1

Exhibit 10.1

ALLONGE TO PROMISSORY NOTE

Allonge (this “Allonge”) to that certain Promissory Note (the “Promissory Note”) attached hereto as Exhibit 1 and made a part hereof in the principal amount of (a) US$500,000.00, dated May 8, 2019, from Bionik Laboratories Corp., as obligor (“Maker”), to Star SCI, as Holder (“Holder”).

Maker and Holder agree that the Promissory Note shall be revised as follows:

1. Clause (ii) of the definition of “Maturity Date” found in Section 1.1 of the Promissory Note shall be amended and replaced to read as follows:

“the date of receipt of an aggregate of $9,000,000 in gross proceeds to the Company from the sale of the Company’s securities subsequent to the Issue Date,”

Except as expressly reflected herein, the Promissory Note will remain in full force and effect. This Allonge is intended to be attached to and made a permanent part of the Promissory Note.

Dated as of the 24 day of September, 2019.

Maker:	BIONIK LABORATORIES CORP.


	By:	/s/ Eric Dusseux
	Name:	Eric Dusseux
	Title:	CEO

Holder:	Star SCI


	By:	/s/ Andre-Jacques Auberton-Herve
	Name:	Andre-Jacques Auberton-Herve
	Title:	President

EXHIBIT 1

PROMISSORY NOTE